Philippine viewers will get to see K-Drama superstars Gong Yoo and Park Bo Gum together for the first time as they star in the highly anticipated Korean sci-fi flick Seobok, which will premiere on SKY Pay-Per-View, commercial-free and in high definition, beginning April 15 (until May 14), the same day it will be released in Korea.
CJ Entertainment's futuristic film revolves around a special agent named Ki Heon (Yoo) and his top-secret task of safely transporting Seobok (Bo-Gum)—the first-ever human clone from a complex stem cell cloning and genetic modification process—to a safe location.
But problems arise as several forces try to abduct the human clone to serve their mischievous agenda. As they escape threats from unknown attackers along the way, Seobok is fascinated with the outside world, longing to learn what it feels like living a normal life.
As a special treat to Korean drama lovers and avid moviegoers, SKY offers an early bird discount promo to its PPV passes, now priced at only P200 until April 14. Regular pricing of P250 takes effect the day after.
Alongside Seobok, SKY Pay-Per-View offers another summer treat for audiences with the showing of intense Pinoy drama film General Admission, starring JC de Vera and Jasmine Curtis-Smith, until April 22—distributed by CineXpress for only P150.
The film helmed by Jeffrey Hidalgo tackles the story of Katja (Jasmine), a noontime show dancer who experiences a wardrobe malfunction in front of the camera. She and her partner, Carlito (JC), are then stuck in a public media frenzy, which leads to a cold and brutal murder.
For more information visit mysky.com.ph/skyppv.
COMMENT DISCLAIMER: Reader comments posted on this Web site are not in any way endorsed by Manila Standard. Comments are views by manilastandard.net readers who exercise their right to free expression and they do not necessarily represent or reflect the position or viewpoint of manilastandard.net. While reserving this publication’s right to delete comments that are deemed offensive, indecent or inconsistent with Manila Standard editorial standards, Manila Standard may not be held liable for any false information posted by readers in this comments section.